Nelson Labs Creates Center of Excellence for Parenteral and Ophthalmic Drug Manufacturing

News
Article

The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Nelson Labs announced on Feb. 14, 2024 that its facility in Itasca, Ill., is being established as a Pharmaceutical Center of Excellence for parenteral and ophthalmic drug product manufacturers. The facility will feature more than 30,000 square feet of space and include instrumentation for full chemistry, manufacturing, and controls (CMC) support.

The laboratory is compliant with current good manufacturing practices and includes a SKAN isolator suite for performing testing for sterility assurance. The suite will add to the lab’s existing sterility assurance capabilities. The lab will also provide support for drug substances, drug products, raw materials, and primary container closure release and stability studies, including high-performance liquid chromatography (HPLC), ultra-high performance liquid chromatography, ion chromatography, LC-mass spectrometry detector (MSD); spectroscopic, including UV-Vis, Fourier transform infrared spectroscopy, and atomic absorption; spectrometric, including Inductively coupled plasma mass spectrometry.

“The development of a Pharmaceutical Center of Excellence at our Itasca laboratory reflects our commitment to providing comprehensive CMC support services for POPD,” said Aryo Nikopour, vice president, Global Segment Leader, Pharma, Nelson Labs, in a press release. “Nelson Labs has been a global leader in laboratory testing for over 35 years, known for its scientific excellence and commitment to quality. We are excited to enter this next stage of world-class testing for pharmaceutical and biopharmaceutical products.”

Nelson Labs provides microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company as more than 3000 customers and facilities in the United States, Mexico, Asia, and Europe. Services include more than 900 laboratory tests and regulatory consulting.

Source: Nelson Labs

Recent Videos
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Related Content